Murray G. Brown

538 total citations
15 papers, 421 citations indexed

About

Murray G. Brown is a scholar working on Pathology and Forensic Medicine, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Murray G. Brown has authored 15 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Economics and Econometrics and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Murray G. Brown's work include Multiple Sclerosis Research Studies (4 papers), Healthcare Policy and Management (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Murray G. Brown is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Healthcare Policy and Management (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Murray G. Brown collaborates with scholars based in Canada, United Kingdom and United States. Murray G. Brown's co-authors include John D. Fisk, Stacy Ackroyd‐Stolarz, Susan Kirkland, R. Lee Kirby, Donald A. MacLeod, Ingrid Sketris, T. Jock Murray, Kenneth Rockwood, Heather Merry and Chris Skedgel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Stroke.

In The Last Decade

Murray G. Brown

15 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murray G. Brown Canada 10 210 111 81 73 51 15 421
Jacek Durmała Poland 15 227 1.1× 136 1.2× 57 0.7× 41 0.6× 14 0.3× 78 1.2k
Rebecca J. Crawford Australia 18 416 2.0× 91 0.8× 48 0.6× 26 0.4× 32 0.6× 58 964
Filippo Maselli Italy 18 148 0.7× 66 0.6× 77 1.0× 25 0.3× 21 0.4× 82 744
Alejandra Cano Spain 10 151 0.7× 123 1.1× 49 0.6× 46 0.6× 57 1.1× 20 602
Christian Hentschke Germany 15 218 1.0× 247 2.2× 58 0.7× 29 0.4× 23 0.5× 29 827
A. Delarque France 17 81 0.4× 235 2.1× 55 0.7× 105 1.4× 20 0.4× 75 887
Elaine Coulter United Kingdom 16 319 1.5× 135 1.2× 147 1.8× 43 0.6× 15 0.3× 26 697
Nicholas Lucas Australia 10 111 0.5× 66 0.6× 30 0.4× 21 0.3× 22 0.4× 26 582
Arthur Ameis Canada 10 188 0.9× 71 0.6× 74 0.9× 17 0.2× 39 0.8× 14 661
Sarah Avery United States 9 265 1.3× 109 1.0× 73 0.9× 34 0.5× 19 0.4× 16 918

Countries citing papers authored by Murray G. Brown

Since Specialization
Citations

This map shows the geographic impact of Murray G. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray G. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray G. Brown more than expected).

Fields of papers citing papers by Murray G. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray G. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray G. Brown. The network helps show where Murray G. Brown may publish in the future.

Co-authorship network of co-authors of Murray G. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Murray G. Brown. A scholar is included among the top collaborators of Murray G. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murray G. Brown. Murray G. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Koch, Marcus, T. Jock Murray, John D. Fisk, et al.. (2014). Hand dexterity and direct disease related cost in multiple sclerosis. Journal of the Neurological Sciences. 341(1-2). 51–54. 17 indexed citations
2.
Brown, Murray G., Mark Asbridge, Sarah Kirby, et al.. (2014). Estimating Typical Multiple Sclerosis Disability Progression Speed from Clinical Observations. PLoS ONE. 9(10). e105123–e105123. 5 indexed citations
3.
Tappenden, Paul, Christopher McCabe, J. Chilcott, et al.. (2009). Cost-Effectiveness of Disease-Modifying Therapies in the Management of Multiple Sclerosis for the Medicare Population. Value in Health. 12(5). 657–665. 49 indexed citations
4.
Chew, Hall F., et al.. (2003). Mortality, Morbidity, and Costs of Ruptured and Elective Abdominal Aortic Aneurysm Repairs in Nova Scotia, Canada. Annals of Vascular Surgery. 17(2). 171–179. 14 indexed citations
5.
Rockwood, Kenneth, Murray G. Brown, Heather Merry, Ingrid Sketris, & John D. Fisk. (2002). Societal Costs of Vascular Cognitive Impairment in Older Adults. Stroke. 33(6). 1605–1609. 61 indexed citations
6.
Jacobs, Philip, et al.. (2002). The Development of a Tool to Assess Quality of Cost Estimates. Disease Management & Health Outcomes. 10(2). 127–132. 2 indexed citations
7.
Brown, Murray G., et al.. (2002). Change and stability in the Canadian healthcare system. Expert Review of Pharmacoeconomics & Outcomes Research. 2(4). 309–312. 3 indexed citations
8.
Brown, Murray G., et al.. (2001). Estimation of Hospital Costs for Colorectal Cancer Care for Nova Scotia. SHILAP Revista de lepidopterología. 15(1). 43–47. 14 indexed citations
9.
Brown, Murray G., T. Jock Murray, Ingrid Sketris, et al.. (2000). COST-EFFECTIVENESS OF INTERFERON BETA-1B IN SLOWING MULTIPLE SCLEROSIS DISABILITY PROGRESSION. International Journal of Technology Assessment in Health Care. 16(3). 751–767. 28 indexed citations
10.
Nagpal, Seema, et al.. (1999). Treatment of Guillain-Barr� syndrome: A cost-effectiveness analysis. Journal of Clinical Apheresis. 14(3). 107–113. 39 indexed citations
11.
Fisk, John D., et al.. (1998). Hospital-based Psychiatric Service Utilization and Morbidity in Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 25(3). 230–235. 34 indexed citations
12.
Kephart, George, et al.. (1995). Coprescribing of nonsteroidal anti-inflammatory drugs and cytoprotective and antiulcer drugs in Nova Scotia's senior population. Clinical Therapeutics. 17(6). 1159–1173. 16 indexed citations
13.
Brown, Murray G.. (1995). Cost-effectiveness. Journal of Ambulatory Care Management. 18(1). 13–28. 4 indexed citations
14.
Sketris, Ingrid, et al.. (1995). Prescribing Patterns of Anttlipemic Drugs and Prevalence of Hypercholesterolemia in the Nova Scotia Population More than 65 Years Old. Annals of Pharmacotherapy. 29(6). 576–581. 4 indexed citations
15.
Kirby, R. Lee, Stacy Ackroyd‐Stolarz, Murray G. Brown, Susan Kirkland, & Donald A. MacLeod. (1994). WHEELCHAIR-RELATED ACCIDENTS CAUSED BY TIPS AND FALLS AMONG NONINSTITUTIONALIZED USERS OF MANUALLY PROPELLED WHEELCHAIRS IN NOVA SCOTIA. American Journal of Physical Medicine & Rehabilitation. 73(5). 319–330. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026